Biography:
Dr. Wei Wu received extensive training in cancer biology and computational biology. He is studying the intricate mechanisms of cancer development and progression, with a specific focus on 1) gene regulatory networks mediated by both protein-coding and non-coding transcripts within the mammalian genome; 2) the landscapes of common and rare somatic mutations and chromosomal structural variations and their genetic alterations occurring within and between tumors. Dr. Wu aims to gain a deeper understanding of the dynamic changes that shape the cancer genome during its evolution. Dr. Wu has published more than 60 research papers and edited 5 biomedical books.
Title : Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer